ATLANTA, Nov. 10, 2015 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming Canaccord Genuity 2015 Medical Technology and Diagnostics Forum on Thursday, November 19, 2015 at the Westin Grand Central Hotel in New York.
A live webcast of the Company's presentation is scheduled to begin at 4:00 p.m. ET and will feature an overview of the company by Pat Mackin, President and Chief Executive Officer.
The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. CryoLife markets and sells products in more than 75 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.
SOURCE CryoLife, Inc.